Tetra Bio Pharma Inc T.TBP

Primary Symbol: TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc

<< Previous

Bullboard Posts

Next >>

Post by SamV21on Aug 14, 2022 2:33am

288 Views

Post# 34894774

Once again saying Revenue before end of year SCAMMER !

Here we go again any day now , you know nothing , you are once again exaggerating to suck people into this SCAM , you think borrowing and dilluting the company is so fantastic . Stop trying to suck people into this ZERO results scam ! The money is to pay wages and thats it !

<< Previous

Bullboard Posts

Next >>

Bombardier completes partial redemption of US$200 million